Megan McKnelly

Megan regularly drafts and negotiates complex collaboration, license, research and services agreements for the development of novel therapeutics, treatments and medical devices.

Megan advises on transactions applying software and artificial intelligence (AI) technologies to R&D and consumer products in the healthcare space and beyond.

Megan counsels clients of all sizes in shaping their IP protection and commercialization strategies by drawing on her experience spanning diverse technology sectors—including life sciences (biotechnology, pharmaceuticals, medical devices and digital health), AI, the Internet of Things, telecommunications, FinTech, cybersecurity and cloud computing.

She also conducts IP diligence for venture capital financings and tech-driven sell-side and buy-side mergers and acquisitions.